Chile‘s Public Health Institute has approved the emergency use of the Russian Sputnik-V vaccine against COVID-19, adding to the country’s already comprehensive immunization program, the institute said in a statement.
One of the institute’s experts voted against the approval and two abstained, calling for more information on the effectiveness of the formula developed by Russia’s Gamaleya Institute. Five members of the committee convened by the institute voted for approval.
“We approve the use of the Sputnik-V vaccine in Chile,” Heriberto García, the institute’s president, said in a statement. The committee evaluated data from Chile and also from Mexico and Argentina, where the Russian vaccine is also applied, he said.
García said that no major side effects of Sputnik-V have been observed. So far, the country has applied at least one dose to 13 million people in its population of 19 million from an arsenal that includes vaccines from Pfizer, AstraZeneca, and Sinovac.